Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
REALIZE FDA DELAY = VERY POSITIVE - We dont know what they filed with the FDA because they never told us being the wonderful communicators that they are. what we do know is that whatever it was it was probably bad. The track record GALT has on clinical trial design is horrendous. RESULTS are Phenomenal but the DESIGNS always suck. They were going to probably have a 2 year study with a read out in year 3. Now shareholders have a chance. they could stop the trial on some people early once they show efficacy.
Shlevin messed the timing and trial up dont give him or the other directors a chance - do not vote for them.
Typical short view point. Wish his self promotable material would stop. His charts never work. This is why shorts love his work.
NEWS STORY and VIDEO NAILED IT - They went current filing status.
Nice to have a media source paying attention to this stuff. I like the video intro with the lead in to an print article.
https://marketnewsfirst.com/mexicana-noticias-primero/f/eastgate-current-filing-status-precursor-toward-big-announcement
Interim Updates Possible! - yes you can put out an update on a clinical trial good or bad. For example the FDA hold on a trial has to be announced . In addition in certain trials its unethical to continue if you are showing efficacy. That was a play from Intercept Pharmas (ICPT) playbook. As long at the company doesnt make any medical claims they will be okay.
Agree its huge but - lets not forget that a licensing deal is very possible.
Phase3 is a layup. Remember this is just oral delivery of insulin. It clearly works. A larger group is needed for approval but the first results were statistically significant so of course phase 3 is going to be fine. Why people have not been flooding into this is beyond me.
did you see the video?
Current is Coming - Friday Anyone? This means we are in the final loading area and prices will need to get bid up. Whoever sells right before it going current is going to hate themsleves.
How come no one is talking about that trade show. This is like a 25K - 50K trade show booth package. These gals are the real deal. This trade show is designed to trap these people. They are hungry for a licensing deal and I think something is cooking. We will see.
We Got Great Order 1.1 million news today. This one order was like more than all of last year. Its crazy why no one was buying.
ATTORNEY CURRENT OPINION LETTER -
https://backend.otcmarkets.com/otcapi/company/financial-report/233043/content
Lots of volume around this. I think all the sellers are out of this. Should grind higher. This current is only the beginning. More news coming.
Current Reporting - Coming soon. I think it could be as soon as tomorrow. The timing works for that.
There is a buyer of size that smacked it to get some panic and then bought all the offers. Very strange way to get 1.0 mil of volume. Look like we finally breached .018
There seems to be clear evidence that this works BUT... I like to look at leader in the field of oxygenation. I think the parallel your draw to the Nobel Prize is interesting but there are way more journal articles that talk about hypoxia. Ever hear of BIXT?
https://www.bioxytraninc.com/press-releases/latest-nobel-prize-validates-bioxytran-at-the-forefront-of-scientific-discovery
See having a needle in your arm for therapy just isnt my type of fun and a lot of people are needle phobic so if you can get more oxygen for longer using a drug like BXT-25 people are going to choose convenience. So they dont get the elimination of toxins mechanically it wont matter if their organs are operating at peak performance because they have a great supply of oxygen.
So your analysis is spot on and I commend you for that but I like to go with best in Breed and have a longer term perspective. BIXT with their development team has a much better chance of getting this approved in cancer. So I share your enthusiasm but cancer is all about Immunotherapy and oxygenation is key during chemotherapy and few people should be using that when immunotherapy is improving so rapidly.
These guys with their technology can go after anything that a hyperbaric chamber can be used for. See the way a hyperbaric chamber operates is by getting more oxygen dissolved into your blood plasma. Since the air we breath is only 20% oxygen only 2% of the oxygen your body gets is from dissolved oxygen in your blood plasma. What a hyperbaric chamber does is increase that. See when you get 100% oxygen in a chamber you are getting 5X what you normally get. That means you are getting 10% oxygen dissolved into the plasma. This is at 1 ATM pressure but at 2 ATM pressure you will get double that and at 3 ATM pressure you will get triple that. So you can get up to 30% oxygen dissolved into blood at 3 ATM.
So instead of staying in a cramped chamber and only getting one hour of hyperbaric treatment with BX-25 the theory is that you can get like 20 Hours of treatment without any of the side effects because you are getting the good oxygen not oxygen that can react and break down your membranes when you put high oxygen concentrations in your blood.
Tiny supply keeps dribbling into the stock. I think that 2.0 million at .018 was real and just decided to parse it out. That means that we are pretty much done based on share count. This baby is ready to rock higher once .018 gets taken out. Any shorts will want to cover on them going current dont you think?
The stock is trading like the calm before the storm. not much volume. This appears to be a good thing because the chart looks primed for a nice up move.
Hey Thanks for the info picked up some shares today. This is good news. Only one reason to keep the filings current right. That means they must be doing something. I think there is something percolating here. Last time this got exposure was due to the linkage to PRED. PRED came back to life in the past couple of day. I see a correlation. Anyone think this could be a merger in the works or maybe a spinoff from PRED? Thoughts?
Hey didnt notice but Look at the news!
https://www.otcmarkets.com/stock/FNGR/news/FingerMotion-Reports-Quarterly-Results-and-Profitability-in-JiuGe-Subsidiary?id=244728
So these guys are Profitable! They need to get a better newswire. This is huge. Look at that quote. We have a gold mine here but no one seems to see it.
Current Filings coming - These guys are so close to being current. Need to get the opinion letter and then they are current. Think it blows through .02 on current news. There is no overhang.
Pretty Quiet here after the Earnings. Anyone look at them? They were pretty good. It looks like they are on their way to being profitable. It would be nice to get some guidance. It'd be nice to see a GTV update. They need to play that up.
MORE NEWS - looks like a great conference for awareness.
https://www.bioxytraninc.com/press-releases/bioxytran-unveiling-concept-of-a-new-vital-sign-at-targeting-mitochondria-world-congress
Seems like these guys are hot on the trail for funding or a licensing deal with all this publicity.
The million share offer was FAKE! So they are trying to keep it down with that so I think something is cooking. has to be. A march to .02 will just take 500K shares. We are so close to a short covering level.
Im reading the same thing. Has to be a reason. Dont think they are doing a money raise though. I think its for a licensing deal or perhaps an uplisting to QB? That would be huge.
NEWS ALERT - Where theres smoke theres fire -
https://www.linkedin.com/in/kam-mahdi-0461b08/detail/recent-activity/
"We would like to thank 2G Energy for the invite to it's partner conference and the opportunity to present our Clean Cycle II ORC waste heat to power (WHP) generator.
It was great to be able to present our principal product and the magnetic levitating bearing technology at the heart of the Clean Cycle generator, which is highly efficient and requires no oil or other lubricants and has no gear box. This key competitive advantage and it’s proprietary technology lowers maintenance costs and improves energy generation than other offerings in the marketplace. Clean Energy Technologies, Inc. (Ticker Symbol "CETY") 2G Energy Inc. (USA) @aarontasin @danjones @emilyrobertson @elskedegroot"
PRESENTATIONS LEAD TO SALES!
Stock is scraping along at the bottom. Looks like a good time to accumulate in here. Business was a little slow last quarter so expecting a nice increase in the coming quarter. The company has a ton of assets. This is a value purchase.
Stock should have been well north of .02 once they were going to get current. Next week they should be current and looking at a potential double from here. Not sure where this supply at .018 came from but I think is was the buyer at .014. The stock is attracting flippers and that is a good thing. Shares are very scarce. It sure would be nice if they can work their magic and get another licensing deal.
FINANCIALS COMPLETE! - NEXT STEP CURRENT
Track Record is Fair. The more indepth the article the higher the conviction of the argument the better the result. I remember their call on INTV - amazing hit. They have written on WEYL before with very good short term results but not good on the long term. Do a search found 5 articles written by them. Long term this stock is a disaster. Re-Read this article and it feels like a lot of effort went into it.
Who knows but the article clearly tells what to look for and when and put targets up that make sense and arent too lofty like its going to moon talk.
MORE FINANCIALS POSTED - They are 1 Quarter away from being Current! This could happen this week at this rate! massive gains to come once this is current. Imagine a definitive licensing deal with current financials.
https://backend.otcmarkets.com/otcapi/company/financial-report/232194/content
NEW ARTICLE- $3.10 Price Target! Seems like a moderator should sticky this DD article.
Massive amounts of info. There is no way GRAB doesn't buy this company. Really connected a lot of dots for me. Very bullish indeed.
Why would an insider pay double the offering in August. Yup almost missed the boat I think. Train leaving the station and he wants to get on board. The guy only has like 3% of the company. its pretty sad for a CEO to say that.
Pretty solid fundamentals too. This is a fundamental, technical, and buyout potential. If I wasnt already in it I would say its a great find.
LINKAGE TO NOBEL PRIZE - https://www.globenewswire.com/news-release/2019/10/16/1930381/0/en/Latest-Nobel-Prize-Validates-Bioxytran-at-the-Forefront-of-Scientific-Discovery.html
Look like a major validation of the technology.
LINKAGE TO NOBEL PRIZE - https://www.globenewswire.com/news-release/2019/10/16/1930381/0/en/Latest-Nobel-Prize-Validates-Bioxytran-at-the-Forefront-of-Scientific-Discovery.html
Look like a major validation of the technology.
The First step is the notice to proceed from the FDA. So I am definitely looking forward to that news like now or maybe next week. They said the beginning of October which is 60 days from their announcement in July. The FDA is required to respond to their letter.
Its a non-issue because unless that supply comes onto the market it will only effect market cap. these people cant clear their stock unless fully reporting company.
This is excellent! The company is making great strides toward being current. A current company gets way more respect. Isnt it interesting how many times in these press releases they mention licensing?
ETBI is a major winner and EXTREMELY UNDERVALUED. The are probably going to have approval in Pakistan soon. They own 100% of it with their JV partner. They could license it to other countries and make a mint. This is a multi billion dollar opportunity. Any money comes into the company on a licensing deal I see a massive upswing in price. Believe it or not its really thin. Only about 300 mil share in the real float. Anyone else calculate out the float. Most of the insiders and consultants own the rest of the company and they CANT sell until the company get current and uplists. When they do get current not expecting they will need any money because all their operations require licensing. The only overhead is the filing of the financials.
There are a lot of small sellers but this sock is just trudging forward. its really nice to see such a good looking chart. Lots of long term holders I think.
Heard a lot more in the way of updates. What happened to GHS capital? I still think they are in ready to provide funding if they get a definitive deal.
CYDY DOESN'T NEED TO DO LARGE CANCER TRIALS! Keytruda and Merck to because of their endpoints. CYDY has a VERY DIFFICULT endpoint to meet. They patients are going to have very high CTC's like in the 150 range and they need to drop it under 5. If they drop it under 5 I think there is a 40% survival benefit in that group of patients. They are going to get BTD really fast. If just 1 person gets under 5 the excitement is going to be off the richter scale. That person just got a 5 year survival rate of 40% minimum but more may be going on here which means it could be a whole lot better.
The key question for tomorrow is how many patients will be doing dose escalation and how long does it take to get up to the therapeutic dose? It may take some time before we hear from the first patient.
What about the Expanded access patient. Are they still alive? Did they get the therapeutic dose. If they did does that mean the Phase 2 trial can start at the therapeutic dose - or dose escalation? Asking these questions will give us a flavor of how long before results come out on an interim basis.
How many other patients have been screened awaiting dosing? Any particluar patient concentration of trial sites?